ClinicalTrials.Veeva

Menu

Study on Prognosis of Acute-on-chronic Liver Failure Complicated by Bacterial or Fungal Infection

Q

Qin Ning

Status

Enrolling

Conditions

Acute-On-Chronic Liver Failure

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The subjects of this study were inpatients with ACLF who were admitted to Tongji Hospital in Wuhan from March 2023 to June 2025. After patients were enrolled, The patient's general information (gender, age, past medical history, etc.), complications (ascites, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, etc.), laboratory tests (CRP, PCT, INR, WBC, fungal/bacterial diagnostic tests, etc.), symptoms and signs at the time of infection, and at admission (D1), D4, D7, D14, D21, etc.) were recorded Save the blood separately. The patients were divided into fungal infection group, bacterial infection group and non-infection group according to the infection status after admission.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. TBIL ≥ 12 mg/mL and INR ≥ 1.5
  2. Chronic hepatitis B

Exclusion criteria

(1) <18 or >80 years old; (2) primary hepatic or extrahepatic carcinoma; (3) with severe diseases of other organs or systems; (4) pregnancy; (5) imcomplete information

Trial design

400 participants in 3 patient groups

non-infection group
Description:
patients without bacterial or fungal infection
bacterial infection group
Description:
patients with bacterial infection
fungal infection group
Description:
patients with fungal infection

Trial contacts and locations

1

Loading...

Central trial contact

Tao Chen, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems